Ignite Creation Date:
2024-05-06 @ 7:50 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06158958
Status:
RECRUITING
Last Update Posted:
2024-06-18
First Post:
2023-11-29
Brief Title:
A Study to Assess the Safety Pharmacokinetics and Efficacy of Intravenous IV ABBV-303 as Monotherapy and in Combination With IV Infused Budigalimab ABBV-181 in Adults With Advanced Solid Tumors
Sponsor:
Organization:
AbbVie